STOCK TITAN

Bristol Myers Squibb to Report Results for Third Quarter 2022 on October 26, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Bristol Myers Squibb (NYSE:BMY) will announce its third-quarter 2022 financial results on October 26, 2022, during a conference call at 8:00 a.m. ET. The call will include a review of the financial results and a Q&A session with investors and analysts. A live webcast is available for the public at investor.bms.com. The call can also be accessed via phone by dialing 877-502-9276 in the U.S. Participants can replay the call starting 11:30 a.m. ET on the same day until November 9, 2022.

Positive
  • None.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) will announce results for the third quarter of 2022 on Wednesday, October 26, 2022. Company executives will review financial results and address inquiries from investors and analysts during a conference call at 8:00 a.m. ET on the same date.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. To be directly connected to the conference call, enter your information here; the link will be active 15 minutes prior to the scheduled start time of the call, and does not require a dial-in number or operator assistance to be connected. Investors and the public can also access the live webcast by dialing in the U.S. toll free 877-502-9276 or international +1 313-209-4906, confirmation code: 8863510. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.

A replay of the webcast will be available on http://investor.bms.com approximately three hours after the conference call concludes. A replay of the conference call will be available beginning at 11:30 a.m. ET on October 26 through 11:30 a.m. ET on November 9, 2022, by dialing in the U.S. toll free 888-203-1112 or international +1 719-457-0820, confirmation code: 8863510.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

Media:

media@bms.com

Investors:

Investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

When will Bristol Myers Squibb announce its Q3 2022 financial results?

Bristol Myers Squibb will announce its third-quarter 2022 financial results on October 26, 2022.

What time is the Bristol Myers Squibb Q3 2022 conference call?

The conference call for the Q3 2022 results will start at 8:00 a.m. ET on October 26, 2022.

How can I access the Bristol Myers Squibb Q3 2022 conference call?

You can listen to the call live at investor.bms.com or by dialing 877-502-9276 for U.S. participants.

When will a replay of the Bristol Myers Squibb Q3 2022 call be available?

A replay will be available starting at 11:30 a.m. ET on October 26, 2022, until 11:30 a.m. ET on November 9, 2022.

What is Bristol Myers Squibb's stock symbol?

Bristol Myers Squibb's stock symbol is BMY.

Bristol-Myers Squibb Co

NYSE:BMY

BMY Rankings

BMY Latest News

BMY Stock Data

118.13B
2.02B
0.12%
78.52%
1.36%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
PRINCETON